Registry study reports feasibility of next-generation sequencing on HIV-1 DNA in suppressed patients with multidrug-resistant HIV, highlighting tools for resistance assessment.
To clarify whether next-generation sequencing (NGS) can be useful for resistance assessment in virologically suppressed highly treatment-experienced (HTE) individuals with MDR HIV.
No takes yet. Share an insight, caveat, or question.
Armenia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: